Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming and epigenetic modifications on the path to cancer
Linchong Sun, Huafeng Zhang, Ping Gao
Protein & Cell (2021) Vol. 13, Iss. 12, pp. 877-919
Open Access | Times Cited: 419

Showing 51-75 of 419 citing articles:

Supramolecular Hydrogel with Ultra‐Rapid Cell‐Mediated Network Adaptation for Enhancing Cellular Metabolic Energetics and Tissue Regeneration
Zhuo Li, Boguang Yang, Zhengmeng Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 11
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Yijia Tang, Guangzu Cui, Haicong Liu, et al.
Cancer Communications (2024) Vol. 44, Iss. 6, pp. 601-636
Open Access | Times Cited: 11
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
Zhaokai Zhou, Jiahui Wang, Jiaojiao Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
The role of NF-κB in carcinogenesis of cervical cancer: opportunities and challenges
Song Deng, Ping Yuan, Jun Sun
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 10
Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer
Zhaolei Cui, Yanhong Li, Yingying Lin, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 10
Relationship between serum β-hydroxybutyrate and hepatic fatty acid oxidation in individuals with obesity and NAFLD
Mary P. Moore, Grace Shryack, Isabella Alessi, et al.
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 4, pp. E493-E502
Closed Access | Times Cited: 9
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 8
Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression
Shujun Zhang, Yafeng Liu, Xiao Ma, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
The Tumor Microenvironment: Signal Transduction
Xianhong Zhang, Haijun Ma, Yue Gao, et al.
Biomolecules (2024) Vol. 14, Iss. 4, pp. 438-438
Open Access | Times Cited: 8
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression
Peng Zhao, Chunzhong Qiao, Jiawei Wang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2078-2089
Closed Access | Times Cited: 8
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access | Times Cited: 1
Methionine-driven methylation modification overcomes plasmid-mediated high-level tigecycline resistance
Dan Fang, Tianqi Xu, Fulei Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis
Xuqing Shen, Yueyue Chen, Yingying Tang, et al.
Cell Reports Medicine (2025), pp. 101928-101928
Open Access | Times Cited: 1
CPLM 4.0: an updated database with rich annotations for protein lysine modifications
Weizhi Zhang, Xiaodan Tan, Shaofeng Lin, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D451-D459
Open Access | Times Cited: 49
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy
Su Zhang, Yang Meng, Lian Zhou, et al.
MedComm (2022) Vol. 3, Iss. 4
Open Access | Times Cited: 34
Research progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer
Xuemei Zeng, Juan Xiao, Xue Bai, et al.
Pathology - Research and Practice (2022) Vol. 238, pp. 154030-154030
Closed Access | Times Cited: 33
Tumor microbiome metabolism: A game changer in cancer development and therapy
Xiaozhuang Zhou, Shruthi Kandalai, Farzana Hossain, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 30
NNMT‐DNMT1 Axis is Essential for Maintaining Cancer Cell Sensitivity to Oxidative Phosphorylation Inhibition
Changqing Wu, Yue Liu, Wenju Liu, et al.
Advanced Science (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 29
PARylated PDHE1α generates acetyl-CoA for local chromatin acetylation and DNA damage repair
Jun Zhang, Feng Chen, Yuan Tian, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 11, pp. 1719-1734
Closed Access | Times Cited: 21
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy
Chenran Wang, Maohua Huang, Yuning Lin, et al.
Nature Metabolism (2023) Vol. 5, Iss. 10, pp. 1765-1786
Closed Access | Times Cited: 20
DNA 5mC and RNA m6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression
Yue Feng, Shihui Guo, Yulan Zhao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1211-1220
Closed Access | Times Cited: 19
Cancer stem cell fate determination: mito-nuclear communication
Mengchen Fan, Ying Shi, Jumei Zhao, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Xinping Cao, Xin Jin, Xiaomei Zhang, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 3, pp. 184-211
Open Access | Times Cited: 16
Epigenetic control of mesenchymal stem cells orchestrates bone regeneration
Xiaofeng Wang, Fanyuan Yu, Ling Ye
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16

Scroll to top